(Q41491098)

1 October 2017

1 reference

title

Biorecognition of antibodies in vivo: potential in drug targeting (English)

1 reference

1 October 2017

Fritzberg AR

1

1 reference

1 October 2017

1 September 1996

1 reference

Journal of Molecular Recognition

1 October 2017

1 reference

1 October 2017

9

1 reference

1 October 2017

5-6

1 reference

1 October 2017

309-315

1 reference

Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects

1 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Imaging lung cancer with radiolabeled antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Antibody-guided scintigraphy: targeting of the "magic bullet".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Recent developments in immunotoxin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

The minimal antigen-binding fragment of antibodies—Fv fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Potential for recombinant immunoglobulin constructs in the management of carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Recombinant toxins as novel therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Single-chain antigen-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Activation of prodrugs by targeted enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Radioimmunotherapy: clinical results and dosimetric considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Biologic properties of a CH2 domain-deleted recombinant immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1352%28199634%2F12%299%3A5%2F6%3C309%3A%3AAID-JMR275%3E3.0.CO%3B2-%23

10.1002/(SICI)1099-1352(199634/12)9:5/6<309::AID-JMR275>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9174904